Neola Medical AB (publ) (STO:NEOLA)

Market Cap	57.84M -67.8%
Revenue (ttm)	8.35M -24.4%
Net Income	-10.99M
EPS	-0.15
Shares Out	77.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,436
Average Volume	30,894
Open	0.7380
Previous Close	0.7580
Day's Range	0.7360 - 0.7420
52-Week Range	0.6020 - 3.0400
Beta	1.24
RSI	19.41
Earnings Date	Feb 12, 2026

About Neola Medical AB

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NEOLA

Financial Performance

In 2024, Neola Medical AB's revenue was 10.12 million, an increase of 2.97% compared to the previous year's 9.83 million. Losses were -10.06 million, 11.7% more than in 2023.